Literature DB >> 29054855

H- ras deletion protects against angiotensin II-induced arterial hypertension and cardiac remodeling through protein kinase G-Iβ pathway activation.

Paloma Martín-Sánchez1,2,3, Alicia Luengo1,2,3, Mercedes Griera1,2,3, María Jesús Orea1, Marina López-Olañeta4, Antonio Chiloeches1, Enrique Lara-Pezzi4, Sergio de Frutos1,2,3, Manuel Rodríguez-Puyol1,2,3, Laura Calleros1,2,3, Diego Rodríguez-Puyol2,3,5,6.   

Abstract

Ras proteins regulate cell survival, growth, differentiation, blood pressure, and fibrosis in some organs. We have demonstrated that H- ras gene deletion produces mice hypotension via a soluble guanylate cyclase-protein kinase G (PKG)-dependent mechanism. In this study, we analyzed the consequences of H- ras deletion on cardiac remodeling induced by continuous angiotensin II (AngII) infusion and the molecular mechanisms implied. Left ventricular posterior wall thickness and mass and cardiomyocyte cross-sectional area were similar between AngII-treated H-Ras knockout (H -ras-/-) and control wild-type (H -ras+/+) mice, as were extracellular matrix protein expression. Increased cardiac PKG-Iβ protein expression in H -ras-/- mice suggests the involvement of this protein in heart protection. Ex vivo experiments on cardiac explants could support this mechanism, as PKG blockade blunted protection against AngII-induced cardiac hypertrophy and fibrosis markers in H -ras-/- mice. Genetic modulation studies in cardiomyocytes and cardiac and embryonic fibroblasts revealed that the lack of H-Ras down-regulates the B-RAF/MEK/ERK pathway, which induces the glycogen synthase kinase-3β-dependent activation of the transcription factor, cAMP response element-binding protein, which is responsible for PKG-Iβ overexpression in H -ras-/- mouse embryonic fibroblasts. This study demonstrates that H- ras deletion protects against AngII-induced cardiac remodeling, possibly via a mechanism in which PKG-Iβ overexpression could play a partial role, and points to H-Ras and/or downstream proteins as potential therapeutic targets in cardiovascular disease.-Martín-Sánchez, P., Luengo, A., Griera, M., Orea, M. J., López-Olañeta, M., Chiloeches, A., Lara-Pezzi, E., de Frutos, S., Rodríguez-Puyol, M., Calleros, L., Rodríguez-Puyol, D. H- ras deletion protects against angiotensin II-induced arterial hypertension and cardiac remodeling through protein kinase G-Iβ pathway activation.

Entities:  

Keywords:  CREB; H-ras−/−; PKG; cardiac hypertrophy

Mesh:

Substances:

Year:  2018        PMID: 29054855     DOI: 10.1096/fj.201700134RRRR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  2 in total

1.  TNF-α elicits phenotypic and functional alterations of vascular smooth muscle cells by miR-155-5p-dependent down-regulation of cGMP-dependent kinase 1.

Authors:  Seunghwan Choi; Minsik Park; Joohwan Kim; Wonjin Park; Suji Kim; Dong-Keon Lee; Jong Yun Hwang; Jongseon Choe; Moo-Ho Won; Sungwoo Ryoo; Kwon-Soo Ha; Young-Guen Kwon; Young-Myeong Kim
Journal:  J Biol Chem       Date:  2018-08-13       Impact factor: 5.157

2.  Rap1GAP Mediates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Inhibiting Autophagy and Increasing Oxidative Stress.

Authors:  Yan Gao; Di Zhao; Wen-Zhi Xie; Tingting Meng; Chunxiao Xu; Yutong Liu; Pengfei Zhang; Xiuping Bi; Zhuo Zhao
Journal:  Oxid Med Cell Longev       Date:  2021-04-15       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.